Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04950075
Title Study of INBRX-109 in Conventional Chondrosarcoma
Acronym ChonDRAgon
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Inhibrx, Inc.
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | AUS

No variant requirements are available.